Clinical Study of the Safety and Efficacy of BAT5906 Injection

NCT04772105 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Macular Edema

Interventions

DRUG: 2.5mg of BAT5906
DRUG: 4.0mg of BAT5906

Sponsor

Bio-Thera Solutions